Impact of Local Tumor Relapse on Patient Survival after Cobalt 60 Plaque Radiotherapy

The authors investigated the impact of local intraocular tumor relapse on survival in a matched-group comparison study of patients with primary choroidal or ciliary body melanoma managed with cobalt 60 plaque radiotherapy. Sixty-two patients with local relapse were matched with an equal number of re...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Ophthalmology (Rochester, Minn.) Minn.), 1991-06, Vol.98 (6), p.984-988
Hauptverfasser:	Vrabec, Tamara R., Augsburger, James J., Gamel, John W., Brady, Luther W., Hernandez, Carlos, Woodleigh, Reginald
Format:	Artikel
Sprache:	eng
Schlagworte:	550603 - Medicine- External Radiation in Therapy- (1980-) 560151 - Radiation Effects on Animals- Man Adult Aged BETA DECAY RADIOISOTOPES BETA-MINUS DECAY RADIOISOTOPES Biological and medical sciences BIOLOGICAL EFFECTS BIOLOGICAL RADIATION EFFECTS Brachytherapy Choroid Neoplasms - mortality Choroid Neoplasms - radiotherapy Ciliary Body - radiation effects COBALT 60 COBALT ISOTOPES Cobalt Radioisotopes - therapeutic use DISEASES Female Follow-Up Studies Humans INTERMEDIATE MASS NUCLEI INTERNAL CONVERSION RADIOISOTOPES ISOMERIC TRANSITION ISOTOPES ISOTOPES Male Medical sciences MEDICINE Melanoma - mortality Melanoma - radiotherapy MELANOMAS Middle Aged MINUTES LIVING RADIOISOTOPES MORTALITY Neoplasm Recurrence, Local - mortality NEOPLASMS NUCLEAR MEDICINE NUCLEI ODD-ODD NUCLEI Ophthalmology PATIENTS POST-IRRADIATION EXAMINATION Prognosis RADIATION EFFECTS RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT RADIOISOTOPES RADIOLOGY RADIOLOGY AND NUCLEAR MEDICINE RADIOTHERAPY RISK ASSESSMENT SURVIVAL CURVES Survival Rate THERAPY Tumors and pseudotumors of the eye, orbit, eyelid, lacrimal apparatus Uveal Neoplasms - mortality Uveal Neoplasms - radiotherapy YEARS LIVING RADIOISOT
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!